hotspot -WSS

hotspot

author：Wikipedia 2025-10-02 22:24:01 - browse：171

A pharmacist hands a box of Wegovy — first opinion coverage from STAT — Bloomberg photo by George Frey

LONDON — Novo Nordisk said Wednesday that it had started to increase the availability of its blockbuster obesity drug Wegovy for new patients in the United States, after massive demand and a supply crunch had led it to limit doses last May.

The announcement that Novo was making more of its lower-dose starter product available as of this month came as the company reported its 2023 earnings, with sales up by 36% and operating profit up 44% at constant exchange rates, driven by enormous sales of Wegovy and Ozempic, the company’s sister drug for diabetes. The company also projected double-digit growth in sales and operating profit for 2024.

“I am pleased to state that we are now enabling more new U.S. patients to initiate treatment by more than doubling the amount of lower-dose strength Wegovy compared to previous months,” Novo CEO Lars Fruergaard Jørgensen said on a call with reporters.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Belarusian journalist sentenced to 4 years in prison as crackdown continues

WSS

Watch the official trailer for 'Ahsoka' series

Rapinoe says her retirement call will help US women's soccer team to focus at World Cup

Why do we get seasonal allergies?

Rapinoe says her retirement call will help US women's soccer team to focus at World Cup

EU fines Illumina $475 million over Grail acquisition

After half a century, Israel moves to evict squatter from his cave home on the beach

focus

hotspot

hotspot

DIEP, the 'gold standard' of breast reconstruction, is under threat

Blinken talks high

New air purifier tech could be key to improving indoor air quality

Tornado touches down near Chicago's O'Hare airport amid extreme weather nationwide

Bright Health sells Medicare Advantage business to Molina

After half a century, Israel moves to evict squatter from his cave home on the beach

BioMarin wins approval for gene therapy to treat hemophilia A

Digital health funding stays low as a new reality sets in

Psychedelics group wrestles with new pharma identity

The debate over Covid

leisure time

Watch the official trailer for 'Ahsoka' series

Here's how to stay safe from wildfire smoke amid reduced air quality

Britney Spears to release memoir, 'The Woman In Me,' later this year

Medical experts exlpore how to eliminate bias in clinical algorithms

Supreme Court strikes down Biden student loan forgiveness program

New lesbian bars spark hope amid disappearing LGBTQ+ spaces

entertainment

leisure time

focus

Wikipedia